Table 1.

Beneficial effect of each formulation in immunized mice

Groups	TTE (days ± S.D.)a	%TGDb	MST(day)c
Buffer	47.59 ± 4.97	–	46.18
P5	77.11 ± 26.65	29.01	Undefined
PADRE	92.36 ± 11.33	20.88	75
CpG	50.98 ± 6.69	6.66	48.3214
PADRE + CpG	69.96 ± 17.73	21.76	81
P5 + CpG	92.36 ± 11.33	40.74	Undefined
DC + P5	75.80 ± 12.96	37.22	64.39
DC + P5 + CpG	90.72 ± 6.89	47.55	Undefined
DC + P5 + PADRE	95.16 ± 0.00	49.99	Undefined
DC + P5 + PADRE + CpG	100.00 ± 0.00	52.41	Undefined

^aTime to reach end‐point.

^bTumour growth delay (in comparison with buffer group).

^cMedian survival time.